The estimated net worth of Krishnan Nandabalan is at least $22.4 M dollars as of April 10, 2023. Krishnan Nandabalan is the Director, 10%+ Owner of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $22.4 M.
Insider Transactions Reported by Krishnan Nandabalan:
Sym
Company
Class
Transaction
%
Value $
Price $
Shares
Shares After
Date
Ownership
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.